Arthrosi Therapeutics, Inc., a clinical-stage biotechnology company, announced the completion of enrollment for its global Phase 2b clinical study of AR882 for the treatment...
Roche announced CE label expansion of the VENTANA PD-L1 (SP263) Assay in non-small cell lung cancer (NSCLC) as a companion diagnostic for Tecentriq® (atezolizumab)....
Tegra Medical, a leading contract manufacturer of medical devices and a member of SFS, which is headquartered in Heerbrugg Switzerland, announced it is expanding...
C2N Diagnostics and Eisai Inc. announced the Companies have entered into a memorandum of understanding that will seek to build awareness about how blood-based...
